Primary systemic therapy in operable breast cancer: clinical data and biological fall-outM Maur, PierFranco Conte, Valentina Guarneri et al.|Annals of Oncology|2006Cited by 39
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyMarina Elena Cazzaniga, Martina Dester, Francesco Atzori et al.|The Breast|2017Cited by 23
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORSM Maur, PierFranco Conte, Federico Piacentini et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005Cited by 2